TURTLE PHARMA PRIVATE LTD

Overview

TURTLE PHARMA PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 6 active FDA Type II Drug Master Files, covering CIPROFLOXACIN HYDROCHLORIDE USP; CIPROFLOXACIN LACTATE; CIPROFLOXACIN USP; ENROFLOXACIN USP; LEVOFLOXACIN HEMIHYDRATE USP; OFLOXACIN USP.

API / Drug Master Files

TURTLE PHARMA PRIVATE LTD holds 6 active (6 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ENROFLOXACIN USPActive2018-10-16
• OFLOXACIN USPActive2018-10-16
• CIPROFLOXACIN HYDROCHLORIDE USPActive2018-10-16
• CIPROFLOXACIN LACTATEActive2018-10-16
• CIPROFLOXACIN USPActive2018-10-16
• LEVOFLOXACIN HEMIHYDRATE USPActive2018-10-16

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to TURTLE PHARMA PRIVATE LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.